Atlanta, GANCT06859801Now EnrollingIRB Ready

Bone Cancer Metastatic Clinical Trial in Atlanta, GA

Access cutting-edge bone cancer metastatic treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.

Sponsored by Society of Interventional Oncology

Quick Self-Assessment

See if you qualify for this Atlanta location

Preparing your pre-screening questions…

Expert Care in Atlanta

Access bone cancer metastatic specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related bone cancer metastatic treatment provided free

Apply for This Atlanta Location

Check if you qualify for this bone cancer metastatic clinical trial in Atlanta, GA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Atlanta

    Convenient for GA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Atlanta site if eligible
  4. 4Begin participation

About This Bone Cancer Metastatic Study in Atlanta

The objective of this study is to evaluate real-world outcomes (e.g., pain, patient reported outcomes, skeletal related events, healthcare utilization, etc.) in patients treated with both percutaneous ablation and palliative radiation therapy (RT).

Sponsor: Society of Interventional Oncology

Who Can Participate

Inclusion Criteria

1\. Skeletal metastasis with localized pain not controlled medically \[recall within last 24 hours of worst pain ≥ 5 using the BPI\]
2\. Pain must be from one painful metastatic lesion involving the bone (additional less painful metastatic sites may be present). Extra-osseous extension of disease is allowed (must have some contact with the bone and be causing bone/tumor interface pain)
3\. Lesions that are at high-risk of skeletal related events defined as follows:
a. Minimum Spinal Instability Neoplastic Score (SINS) score ≥ 7 for lesions involving the spine
b. Pelvic and appendicular lytic lesions with or without cortical breakthrough causing functional/mechanical pain
4\. Target lesion amenable to percutaneous ablation with image guidance AND RT by specialists' review
5\. No prior targeted radiation therapy or ablation to the index lesion
6\. ECOG performance status 0-2
7\. Age ≥ 21 years
8\. Have signed the current approved informed consent form
9\. Willing and able to answer follow-up Patient Reported Outcomes (PRO) surveys (e.g., PROMIS®, BPI, COST-FACIT, and OMED) for up to 12 months
10\. Life expectancy \> 3 months

Exclusion Criteria

1\. Any medical or personal condition that, in the opinion of the site investigator, may potentially compromise the safety or compliance of the patient, or may preclude the patient's successful completion of the clinical trial.
2\. Target tumor involves a weight-bearing long bone of the lower extremity with the tumor causing \> 50% loss of cortical bone \[MIREL Score ≥ 7\]
3\. Skeletal lesions with unstable pathologic fractures requiring immediate surgical stabilization
4\. Concurrent participation in other studies that could affect the primary endpoint
5\. Target tumor causing clinical or imaging evidence of spinal cord compression

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Atlanta?

Yes, this clinical trial (NCT06859801) has an active research site in Atlanta, GA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Bone Cancer Metastatic Treatment Options in Atlanta, GA

If you're searching for bone cancer metastatic treatment options in Atlanta, GA, this clinical trial (NCT06859801) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bone cancer metastatic specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all bone cancer metastatic clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Atlanta, GA

See all essential tremor clinical trials recruiting in Atlanta — not just this study.

Browse Essential Tremor Trials in Atlanta →

Browse More Trials by Condition

Essential Tremor TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Atlanta?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Atlanta, GA